Glutathione (TAD) 600mg/4mL IV/IM
US$ 25.75
ghk cu typical dose subcutaneous ghk-cu peptide dosage injection ghk-cu typical subcutaneous injection WO2019167070A1 GHK-Cu Dosing: 1.7mg/Day Injectable (2026)
Description
Each compound is supplied for in-vitro use only and is not approved for human use
The docket stays open until July 22, 2026
Customer support We've dealt a lot with Life Extension customer support over the years, and they've always been speedy, responsive, and helpful
Be the first
The mechanisms overlap with GHK-Cu but aren't identical
The dominant model is acute surgical transection or chemical injury in rats, evaluated over short-to-medium time courses
